Kirk Bechdel Email & Phone Number

Maryland, United States

• Promote the use of UNITY to OBGYN and Maternal Fetal Medicine practices in Maryland. UNITY is the first and only non-invasive prenatal test that can provide a fetal risk assessment for ACOG recommended recessive.
• Work in a cross-functional collaboration with Leadership, Sales Operations, Medical Science Liaisons, Genetic Counselors, Patient Billing, Patient Access Programs, Client Services, EMR Integration Team, Client.
• Mastered the offerings and processes of BillionToOne’s genetic tests and services to help patients and ethically drive demand.
• Understand competition to be able to differentiate UNITY and how it can uniquely benefit patients.
• Developed territory from the ground up using specific strategies based on the business model/IDN structure of each account in a crowded, complicated and competitive marketplace.
• Increased the number of UNITY kits received for 9 of 10 quarters. Grew the number of tests in Maryland from nearly 0 to almost 800 tests per quarter in 2.5 years.

Baltimore, Maryland, United States

• Accelerated uptake of Cologuard, a non-invasive screening test for colorectal cancer. Proactively identified and built relationships with decision makers among primary targets, while also identifying new business.
• 4Q 2021 quota attainment finished at 109% for shipments, and 118% for returns, a top 15% National ranking.
• Wrote an Excel macro to convert raw Coaching Workbook data to a more user-friendly version, saving teammates significant time by automatically performing over 40 formatting steps.
• Succeeded in hitting 100% Pace-To-Quota for 2Q 2021, which was a 23% increase over baseline (2nd largest baseline quota increase in the Mid-Atlantic Region).
• Devised a new Rescreen Strategy leveraging EMR to help offices improve their colorectal cancer screening rates, which was sent to the Sales Excellence group for evaluating potential use as a national sales resource.
• Achieved an increase over prior week, in average daily kit return, 10 of 13 weeks for 3Q 2020.

Maryland And Delaware

• Promoted Repatha (biologic subcutaneous injectable indicated to reduce the risk of MI, Stroke and Revascularization), and launched Aimovig (biologic subcutaneous injectable preventive treatment for Migraine) to.
• Worked with the Field Reimbursement Manager to help health care providers navigate the Specialty Pharmacy/HUB to get patient approval and coverage for Aimovig during the launch phase.
• Overall S1 ranking for Repatha was 3 of 46 in the Nation for a Top 9% finish (October 2018 - March 2019).
• Launched Aimovig, first in class CGRP antagonist for Migraine, achieving a 190% Growth Rate for 1S.

Baltimore, Maryland Area

• Bristol-Myers Squibb sold their half of the Diabetes Franchise to their alliance partner, AstraZeneca at the end of 2013. As an AZ employee, I launched and developed business for every product in the Diabetes.
• Worked closely with KOL advocate (nephrologist) to help educate on Farxiga, first-in-class SGLT2 blocker
• Reached top 24% Circle of Excellence national performance ranking for 1S 2017 (295 of 1,265)
• Attained top 20% Circle of Excellence national performance ranking in 2016 (138 of 687)
• 4Q 2016 Geography Portfolio Achievement was 137.88%. Final Rank was 23 of 189 and 67 of 189 for Farxiga Family and Bydureon Pen, respectively
• Promoted to Senior Diabetes Sales Specialist in October, 2015

Baltimore, Maryland Area

Bristol-Myers Squibb rolled the inVentiv Health contract Diabetes Sales Specialists into the company in September, 2013.Promoted the Diabetes portfolio, including Onglyza and Kombiglyze XR (once-daily tablets), and Bydurion (once-weekly subcutaneous injectable) to Internal Medicine, Family Practice, Long-Term Care, and Endocrinologists.

Baltimore, Maryland Area

Started on the inVentiv Health contract with Amylin to launch Bydurion (once-weekly subcutaneous injectable). When Bristol-Myers Squibb purchased Amylin in early 2013, the inVentiv Health contract continued with BMS.Promoted the Diabetes portfolio, including Bydurion, Onglyza and Kombiglyze XR (once-daily tablets which I had launched on the previous BMS.

Baltimore, Maryland Area

Started Healthy Vending Options to gain the experience of owning and operating a small business. HVO focused on the sale of healthier snacks and drinks in vending machines located in corporate offices.

Baltimore, Maryland Area

• Advanced sales of Plavix (Atherothrombosis / Antiplatelet), Avapro/Avalide (Hypertension), and launched and promoted Onglyza and Kombiglyze XR (Diabetes) to Internal Medicine, Family Practice, Vascular Specialists and.
• Achieved Pinnacle Award (BMS’s version of President’s Club) three consecutive years in 2009, 2010 and 2011
• Delivered top 10% results in Nation to win the Kombiglyze XR Take Control launch contest in May 2011
• Earned the #1 overall Region ranking for territory performance in 2009 and 2010
• Won the Onglyza Trialist contest in June 2010 by being the first territory in the Region to have more than 40% of targeted physicians write Onglyza
• Succeeded in winning the Onglyza Launch contest in November 2009 by delivering the most scripts written in the Nation

Baltimore, Maryland Area

• Promoted ZOCOR (Cholesterol), SINGULAIR (Asthma and Allergies) and VIOXX (Arthritis / Pain Management); launched and promoted ZETIA and VYTORIN (Cholesterol) to Internal Medicine, Family Practice, Pediatricians.
• Director’s Club Award for 2008 by finishing in the Top 20% in the Region
• Award for Excellence and Special Achievement Award for two projects impacting the District, Region and Nation in 2005 and 2006 (see “Special Projects” below)
• District MVP Award for 2005
• Director’s Club Award for 2005 by finishing in the Top 20% in the Region
• Vice President’s Club Award for 2004 by finishing in the Top 10% in the Region

Ba, Speech Communication

Activities and Societies: Beta Theta Pi Fraternity

Education record